Targeted genetic-based healthcare can change our lives
We have to change the laboratory industry to make it happen
BioConnetiX advances transformation within the laboratory industry
with a first-of-its kind solution that incorporates operations and technology
At BioConnetiX, we believe that evidence-based genetic medicine should be the standard of care, not the "luxury" care that it is today. We believe this so strongly, in fact, that our entire company was designed around this bold mission. This meant that we had to question everything we "traditionally" practiced in both laboratories and medical practices. What we realized was that science and medicine had incredible existing talent. While everyone else seemed to be coming up with a new lab or a new test or new medical practice, we thought: "Why don't we just build something that connects all of the existing great?"
The solution to managing cost and access within genetic-based care is in connecting existing resources
With this as our foundation, BioConnetiX developed software to connect existing resources, and then created process and operations protocols that could transform fragmented, costly laboratory testing into evidence-based, personalized care from a foundation in genetic science.
BioConnetiX is the first healthcare platform of its kind to harness physician, scientist, and operator specialization to comprehensively manage the entire supply chain in the continuum of laboratory care.
Our Partners | The Supply Chain for Genetic-Based Care
We partner with research institutions, molecular pathologists, scientists, and independent laboratories. These are the critical specialists required to supply precision medicine to the providers who deliver care. We catalyze change through extensive collaboration with our partners, leveraging repeatable processes, regimented operations, and sophisticated technology to make on-boarding and on-going participation efficient.
Partners integrate at their own pace and remain completely independent. Participation is open to any laboratory, pathology practice, or research institution who can meet our ambitious standards.
Systematic Processes | Consistent Results
Challenges in genetic laboratory testing are addressed both systematically and effectively – dramatically lowering costs while advancing the creation and adoption of comprehensive care based on individual genetic variation. Partner Laboratory Integration follows a regimented course beginning with proficiency-based assessment and advancing through 10 total outcomes-based levels of cost and utilization control, operational efficiency, collaboration, specialization, reporting, technology integration, and pathway-based workup and care management.
The Laboratory Operational Solution | INTEGRATE
Through the operational side of the platform, base testing needs are performed within an efficient networked system of laboratories proximate to patients, and new evidence-based protocols are commercialized economically through cooperative planning that includes capacity requirements, resource planning, location planning, and operator specialization.
Integrated laboratories are afforded access to offer all new tests, studies, protocols, and specialists within their existing network. They also become eligible to participate in validations for new EBM-based protocols and receive test volume from throughout the network for achieving scientific performance, operational turnaround, and cost benchmarks.
This allows healthcare systems and networks the ability to launch new evidence-based protocols simultaneously, dramatically accelerating access to care for patients while lowering the cost of testing. Aligned validations beget economies of scale through centralization of inventory & shipping management, as well as combined test menus, automated routing based on test need, and flexibility to manage complex evaluations and care plan needs with molecular pathologists or other specialists efficiently through a connected telehealth-type network.
symbio6 cognitive software was architected specifically for the efficient delivery of genetic-based care. Our goal was to create an agnostic technology platform that could overcome the barriers faced by every healthcare entity, and then make it open to any entity.
Our Design-Thinking Process | symbio6
When creating the blueprint for symbio6, we undertook an extensive design-thinking approach involving experts from every aspect of medicine, business, and technology. The design team planned with doctors of all specialties as well as experts in laboratory, insurance, billing, claims, merchant services processing, practice management, laboratory compliance, & healthcare law.
Re-Designing the Re-Design | symbio6 from a World-View
Just when we thought we had the software blueprint right, we decided to see what symbio6 looked like from a world-view, realizing that if we could create a solution that worked for everyone, we had a much better shot at creating one that could work for anyone. The world-view approach sent us back to the drawing board with many of the modules - forcing us to become much leaner, smarter, connected, and user friendly.
Module Testing | symbio6
Most initial modules were launched outside of the US, many in 3rd world countries. We felt this would really put us, and our solution, to the test. Could we efficiently connect the entire supply chain? Could we centralize medical supply inventory management? Could our portals work for everyone we wanted to serve? Could we create risk-based decision tools that calculated & reported outcomes? Could we manage complex billing & claims rules to suit many different regulations and payers? Could our interfaces be user-friendly enough for patients to manage their own medical record? Could we make it affordable?
On October 1, 2018 - 5 countries, 2 governments, 85 practices, 921 providers, and 500,000 patients later, we said yes.
Cognitive Software with a little Technobot Genius | symbio6
translates discreet results from any lab
centralizes patient record - results, genes, personal care guidelines
seamless, HIPAA-compliant data exchange & emergency access
plug-and-play modules work as both front-end and back-end solutions
portals thoughtfully designed for every type of platform user
BioConnetiX connects the healthcare ecosystem
Genetic-Based Care Demands Connected Delivery
Connected Delivery Allows Specialists to Specialize
Academics can innovate with the peace of the mind that evidence-based discoveries can be quickly and cost-effectively shared through a collaborative network. Pathologists can continue to discover while also practicing medicine through remote clinical workup and care plan creation for complex and specialized disease processes. Independent Laboratories can leverage their scientific talent to advance genomic medicine and focus on operations that lower the cost of care. Medical providers can provide personalized care with assurance and efficiency. Insurance Companies and other payors of healthcare can ensure expenditures are properly utilized and can leverage healthcare dollars to cover more genetic health services. Public Health systems can economically launch initiatives that improve population health. Healthcare systems and government networks can connect laboratories systematically and affordably to achieve economies of scale for large-scale testing needs as well as cost-effective access to specialty tests. Pharmaceutical companies can access better mechanisms for safely delivering new drugs and biologics with pharmacogenomic dose guidance.
measured, managed genetic-based care
is made possible by connecting the ecosystem
Genetic-Based Care Demands Access to
The mapping of the human genome in 2003 birthed molecular diagnostics and the promise of molecular pathologic medicine. The complex depth of knowledge required to deliver genomic medicine led to exponential growth in completely new types of physician specialists. To put the growth in perspective, in the year 2000 there were 14 ACGME-accredited selective pathology fellowships. By 2014, there were 62 new molecular pathology specialties. Access to this rapidly growing group of experts is critical to properly manage care.
Genetic-Based Care Demands Access to
Research Institutions and Universities around the world collaborate extensively to bring create evidence-based medical applications derived from molecular science. Testing protocols & treatments on 1.4 million SNP's, or places along our DNA where disease-specific differences have been discovered, is costly, and incredible cures only possible through collaboration with these academics.
Genetic-Based Care Demands Access to
Life-saving genetic cures are worthless without the ability to bring the science to life and provide access affordably on a mass scale. Independent laboratories are ideal for translating research procedures into diagnostic assays. This existing network of operators has the scientific acumen and structure required for both specialization and standardization - the critical elements for cost management, turnaround time assurance, and access to care delivery.
Genetic-Based Care Demands Fusion of
Labs & Medicine
Evidence-based clinical pathways are made possible through academic pathologists. Protocols are controlled and made efficient with robust decision-support technology. Our partner laboratories integrate by medical specialty to allow for immediate utilization controls and a structured path to work-up based test offerings based on evidence-based medicine. Operators and scientists work hand-in-hand with molecular academics, and are the key to ensuring tests are performed cost-effectively, accurately, and consistently.